Combined liver resection and reconstruction of the supra-renal vena cava: The Paul Brousse experience

Annals of Surgery

Volumn 244, Issue 1, 2006, Pages 80-88

  Azoulay, Daniel ^a   Andreani, Paola ^a   Maggi, Umberto ^a   Salloum, Chadi ^a   Perdigao, Fabiano ^a   Sebagh, Mylène ^a   Lemoine, Antoinette ^a   Adam, René ^a   Castaing, Denis ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CATHETER INFECTION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LIVER VEIN; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SUPERIOR CAVA VEIN; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR RECURRENCE; VASCULAR SURGERY; VEIN SURGERY; BLOOD VESSEL TRANSPLANTATION; CANCER INVASION; INFERIOR CAVA VEIN; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PEROPERATIVE COMPLICATION;

ADULT; AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HEPATECTOMY; HUMANS; INTRAOPERATIVE COMPLICATIONS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE COMPLICATIONS; VASCULAR SURGICAL PROCEDURES; VENA CAVA, INFERIOR;

EID: 33747500293     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000218092.83675.bc     Document Type: Article

References (69)

1. Fong Y. Surgical therapy of hepatic colorectal metastases. CA Cancer J Clin. 1999;49:231-255.
2. Song T-J, Wai Kit Ip E, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology. 2004;127(suppl):248-260.
3. Bismuth H, Adam R, Lévi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509-522.
4. Lévi F, Zidani R, Brianza S, et al. A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma: International Organization for Cancer Chronotherapy. Cancer. 1999;85:2532-2540.
5. De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938-2947.
6. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000;18:136-147.
7. Rougier P, Van Custem E, Bajetta E, et al. Randomized trial of irinotecan vs fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet. 1998;35:1407-1412.
8. Douillard J-Y, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet. 2000;355:1041-1047.
9. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992;163:387-394.
10. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777-785.
11. Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003;238:871-883, discussion: 883-884.
12. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480-486.
13. Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665-672.
14. Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332-1339.
15. Elias D, Gohanin A, El Otmany A, et al. Usefulness of intraoperative radiofrequency thermoablation of liver tumors associated or not with hepatectomy. Eur J Surg Oncol. 2000;26:763-769.
16. Parikh AA, Curley SA, Fornage BD, et al. Radiofrequency ablation of hepatic metastases. Semin Oncol. 2002;29:168-182.
17. Heaney JP, Stanton WK, Halbert DS, et al. An improved technique for vascular isolation of the liver: experimental study and case reports. Ann Surg. 1966;163:237-241.
18. Huguet C, Nordlinger B, Galopin J, et al. Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg Gynecol Obstet. 1978;147:689-693.
19. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg. 1989;210:13-19.
20. Azoulay D, Eskenazy R, Andreani P, et al. In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg. 2005;241:277-285.
21. Starzl TE, Koep LJ, Weil R III, et al. Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet. 1980;150:208-214.
22. Iwatsuki S, Todo S, Starzl TE. Right trisegmentectomy with a synthetic vena cava graft. Arch Surg. 1988;123:1021-1022.
23. Kumada K, Shimahara Y, Fukui K, et al. Extended right hepatic lobectomy: combined resection of inferior vena cava and its reconstruction by PTFE graft (goretex). Case report. Acta Chir Scand. 1988;254:481-483.
24. Risher WH, Arensmn RM, Ochsner JL, et al. Retrohepatic vena cava reconstruction with polyfluoroethylene graft. J Vasc Surg. 1990;12:367-370.
25. Miller CM, Schwartz ME, Nishizaki T. Combined hepatic and vena caval resection with autogenous caval graft replacement. Arch Surg. 1991;126:106-108.
26. Sakaguchi S, Hishiki S, Nakamura S, et al. Extension incision for renal carcinoma including invaded vena cava and right lobe of the liver. Urology. 1992;39:285-288.
27. O'Malley KJ, Stuart RC, McEntee GP. Combined resection of the inferior vena cava and extended right hepatectomy for leiomyosarcoma of the retrohepatic cava. Br J Surg. 1994;81:845-846.
28. Yagyu T, Shimizu R, Nishida M, et al. Reconstruction of the hepatic vein to the prosthetic inferior vena cava in right extended hemihepatectomy with ex situ procedure. Surgery. 1994;115:740-744.
29. Grazi GL, Mazziotti A, Jovine E, et al. Total vascular exclusion of the liver during hepatic surgery: selective use, extensive use, or abuse? Arch Surg. 1997;132:1104-1109.
30. Ohwada S, Kawashima Y, Ogawa T. Extended hepatectomy with ePTFE graft vena caval replacement and hepatic vein reconstruction: a case report. Hepatogastroenterology. 1999;46:1151-1155.
31. Enoki T, Hayashi D, Inokuchi T, et al. Combined right hepatic and retrohepatic caval resection with reconstruction using a polyfluoroethylene graft for primary leiomyosarcoma of the liver: report of a case. Surg Today. 1999;29:67-70.
32. Zografos GN, Palmer S, Papastratis G, et al. Aggressive surgical management of fibrolamellar hepatocellular carcinoma in puberty. Eur J Surg Oncol. 1997;23:570-572.
33. Yamamoto Y, Terajima H, Ishikawa Y, et al. In situ pedicle resection in left trisegmentectomy of the liver combined with reconstruction of the right hepatic vein to an inferior vena caval segment transpositioned from the infrahepatic portion. J Am Coll Surg. 2001;192:137-141.
34. Lechaux D, Magavand JM, Raoul JL, et al. Ex vivo right trisegmentectomy with reconstruction of inferior vena cava and 'flop' reimplantation. J Am Coll Surg. 2002;194:842-845.
35. Del Campo C, Konok GP. Use of a pericardial xenograft patch in repair of resected retrohepatic vena cava. Can J Surg. 1994;37:59-61.
36. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg. 1982;6:3-9.
37. Couinaud C. Le foie Etudes anatomiques et chirugicales. Paris: Masson et Cie, 1957.
38. Nagasue N, Yukaya H, Ogawa Y, et al. Segmental and subsegmental resections of the cirrhotic liver under inflow and outflow occlusion. Br J Surg. 1985;72:565-568.
39. Elias D, Lasser P, Debaene B, et al. Intermittent vascular exclusion of the liver (without vena cava clamping) during hepatectomy. Br J Surg. 1995;82:1535-1539.
40. Cherqui D, Malassagne B, Colau P, et al. Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann Surg. 1999;230:24-30.
41. Azoulay D, Hargreaves GM, Castaing D, et al. The anterior approach: the right way for right massive hepatectomy. J Am Coll Surg. 2001;192:412-417.
42. Delva E, Barberousse JP, Nordlinger B, et al. Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery. 1984;95:309-318.
43. Fortner JG, Shiu MH, Kinne DW, et al. Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg. 1974;180:644-652.
44. Oken AC, Frank SM, Merritt WT, et al. A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 1994;8:58-60.
45. Budd JM, Isaac JL, Bennett J, et al. Morbidity and mortality associated with large-bore percutaneous venovenous bypass cannulation for 312 orthotopic liver transplantations. Liver Transplantation. 2001;7:359-362.
46. Shaw BW, Martin DJ, Marquez JM, et al. Venous bypass in clinical liver transplantation. Ann Surg. 1984;200:524-534.
47. Belghiti J, Noun R, Zante E, et al. Portal triad clamping or hepatic vascular exclusion for major liver resection: a controlled study. Ann Surg. 1996;224:155-161.
48. Liu DL, Jeppsson B, Hakansson CH, et al. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg. 1996;131:442-447.
49. Johnson SR, Marterre WF, Alonso MH. A percutaneous technique for venovenous bypass in orthotopic cadaver liver transplantation and comparison with the open technique. Liver Transpl Surg. 1996;2:354-361.
50. Berney T, Mentha G, Morel P. Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg. 1998;85:485-488.
51. Hemming AW, Reed AI, Langham MR, et al. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg. 2004;239:712-721.
52. Kaneko T, Nakao A, Nomoto S, et al. Intracaval endovascular ultrasonography for preoperative assessment of retrohepatic inferior vena cava infiltration by malignant tumors. Hepatology. 1996;24:1121-1127.
53. Kikumori T, Imai T, Kaneko T, et al. Intracaval endovascular ultrasonography for large adrenal and retroperitoneal tumors. Surgery. 2003;134:989-993.
54. Herring M, Gardner A, Peigh P, et al. Patency on canine vena cava grafting: effects of graft material, site, and endothelial seeding. J Vasc Surg. 1984;1:877-887.
55. Smith D, Hammon J, Anane-Sefah R, et al. Segmental venous replacement: a comparison of biological and synthetic substitutes. J Thorac Cardiovasc Surg. 1975;69:589-598.
56. Hardwigsen J, Balandraud P, Ananian P, et al. Leiomyosarcoma of the retrohepatic portion of the inferior vena cava: clinical presentation and surgical management in five patients. J Am Coll Surg. 2005;200:57-63.
57. Bower TC, Nagorney DM, Cherry KJ Jr, et al. Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg. 2000;31:270-281.
58. Sarmiento JM, Bower TC, Cherry KJ, et al. Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy? Arch Surg. 2003;138:624-631.
59. Takayama T, Makuuchi M, Kosuge T, et al. A hepatoblastoma originating in the caudate lobe radically resected with the inferior vena cava. Surgery. 1991;109:208-213.
60. Huguet C, Ferri M, Gavelli A. Resection of the suprarenal inferior vena cava: the role of prosthetic replacement. Arch Surg. 1995;130:793-797.
61. Dekett JW, Gittes RF. Resection of the inferior vena cava for adjacent malignant disease. Surg Gynecol Obstet. 1973;136:711-716.
62. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240:1052-1064.
63. Glasgow RE, Showstack JA, Katz PP, et al. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg. 1999;134:30-35.
64. Edwards EB, Roberts JP, McBride MA, et al. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med. 1999;341:2049-2053.
65. Madariaga JR, Fung J, Gutierrez J, et al. Liver resection combined with excision of vena cava. J Am Coll Surg. 2000;191:244-250.
66. Oldhafer KJ, Lang H, Schlitt HJ, et al. Long-term experience after ex situ liver surgery. Surgery. 2000;127:520-527.
67. Hardwigsen J, Baqué P, Crespy B, et al. Resection of the inferior vena cava for neoplasms with or without prosthetic replacement: a 14-patients series. Ann Surg. 2001;233:242-249.
68. Maeba T, Okano K, Mori S, et al. Retrohepatic vena cava replacement of hepatic malignancies without using total hepatic vascular exclusion or extracorporeal bypass. Hepatogastroenterology. 2001;48:1455-1460.
69. Arii S, Teramoto K, Kawamura T, et al. Significance of hepatic resection combined with inferior vena cava resection and its reconstruction with expanded polytetrafluoroethylene for treatment of liver tumors. J Am Coll Surg. 2003;196:243-249.